OptiScanner® 5000 Glucose Monitoring System— 510(k) K192785
Substantially EquivalentOptiscan Biomedical Corporation
FDA 510(k) clearance K192785 for OptiScanner® 5000 Glucose Monitoring System, Substantially Equivalent on 2020-02-05. Applicant: Optiscan Biomedical Corporation.
Clearance details
- Applicant
- Optiscan Biomedical Corporation
- Product code
- Code LZF
- Advisory panel
- General Hospital
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Hayward, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.